EUCTR2011-002147-10-AT进行中（未招募）不适用
Influenza vaccination in old age: Immunological and biogerontological characterization of responders and non-responders - Influenza vaccination in old age
Institute for Biomedical Aging Research0 个研究点开始时间: 2011年8月16日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •signed informed consent form
- •participant of the former MARK-AGE study
- •no previous influenza vaccination in the 2011/2012 season
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 150
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 150
排除标准
- •acute illness
- •chronic inflammatory disease (e.g. inflammatory bowl disease, Multiple Sclerosis)
- •chronic infection with HBV, HCV or HIV
- •transplant recipients
- •persons who have recieved chemotherapy in the past
- •persons under immunosuppressive therapy
- •pregnant women
- •participation in another clinical trial during the study
研究者
相似试验
招募中
不适用
Influenza Immunization in Adults Over Age 75ImmunizationOlder AdultsOver Age 75InfluenzaNCT02200276Johns Hopkins University1,025
招募中
4 期
Immune responses in health care personnel2024-515372-12-00Finnish Institute For Health And Welfare1,500
进行中（未招募）
4 期
Flu Vaccine Responses in the Setting of Melanoma TreatmentViral VaccinesNCT03315975University of Pennsylvania40
进行中（未招募）
1 期
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibTo assess the immune response to an influenza vaccine in subjects with B-cell malignancies treated with idelalisibMedDRA version: 20.0 Level: PT Classification code 10065856 Term: Non-Hodgkin's lymphoma unspecified histology indolent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-003055-30-ESGilead Sciences, Inc.22
进行中（未招募）
1 期
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibTo assess the immune response to an influenza vaccine in subjects with B-cell malignancies treated with idelalisibMedDRA version: 20.0 Level: PT Classification code 10065856 Term: Non-Hodgkin's lymphoma unspecified histology indolent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-003055-30-CZGilead Sciences, Inc.22